Navigation Links
Mindray's DC-3 Color Ultrasound Gains U.S. FDA 510(k) Clearance

SHENZHEN, China, June 6 /Xinhua-PRNewswire/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced it has received 510(k) clearance from the United States Food and Drug Administration ("FDA") for its DC-3 color ultrasound imaging system. The clearance comes in addition to China State Food and Drug Administration ("SFDA") approval and CE Mark granted earlier this year for the sale of the DC-3 in Chinese and European markets, respectively.

"The compact DC-3 combines outstanding 2D imaging and exceptional color Doppler performance," said Mr. Li Xiting, Mindray's president and co-chief executive officer. "With a superior price-to-performance ratio, we are confident that this versatile product will meet the diverse needs and requirements of hospitals, doctors' offices and veterinary clinics around the world."

The DC-3 color ultrasound imaging system is designed to have extensive applications in abdominal, OB/GYN, endovaginal, cardiac, small parts and pediatric markets. The product is ideally suited for U.S. hospitals, doctors' offices and veterinary clinics seeking to replace black and white ultrasound imaging systems. The DC-3 is tailored to expand Mindray's customer base in low-end markets and complements the company's FDA-approved DC-6 and portable M5 ultrasound imaging systems, which are targeted for middle and high-end markets and received FDA 510(k) clearance in September, 2006 and March, 2008, respectively. The company currently offers over 10 medical imaging products of which five have received FDA 510(k) clearance.

Mindray has to date received FDA 510(k) clearance for a total of 16 products, covering patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems.

About Mindray

Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring & life support products, in-vitro diagnostic products and medical imaging systems. Mindray is globally headquartered in Shenzhen, China, with U.S. headquarters in Mahwah, New Jersey. Mindray also has sales and service offices internationally in Amsterdam, Istanbul, London, Mexico City, Moscow, Mumbai, Sao Paulo, Seattle, Toronto and Vancouver. For more information, please visit .

For investor inquiries please contact:

In China:

Susan Du

Mindray Medical International Limited

Tel: +86-755-2658-2518


Justin Knapp

Ogilvy Public Relations Worldwide, Beijing

Tel: +86-10-8520-6556


In the United States:

Jeremy Bridgman

Ogilvy Public Relations Worldwide, New York

Tel: +1-212-880-5363

SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Wal-Mart Expands $4 Prescription List in Colorado
2. Baxa Corporation Named Finalist for Third Year as a Best Company to Work For in Colorado
3. Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th
4. Family history of colorectal cancer linked with reduced risk of cancer recurrence
5. Canine Cancer Web Exclusive for Dog Owners and Lovers, Presented by Morris Animal Foundation - Features Colorado State and Cornell University Veterinary Cancer Experts
6. Gentiva(R) Health Services Acquires Leading Colorado Home Health Provider
7. Sundays AIDS Walk Boston at the Esplanade Gets Tribute from Cyndi Lauper at True Colors Concert Tour Launch Rehearsal
8. USC study finds sex, age and ethnicity assciated with colorectal cancer survival
9. TV Commercials Color Gender Choices for Careers
10. Can pathological techniques help identify primary colorectal signet ring cell carcinoma?
11. New Method Proposed for Determining Which Patients Should Get Treatment for Colorectal Cancer
Post Your Comments:
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever ... Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation ... as home to some of the world’s leading providers of cereal and other breakfast ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: